CE Ventures
60+ companies
5 partners
Meet the Team
Bruce Hong
General Partner
Currently the CEO and Director of CapitalEnergy Corporation, the parent company of CE Venture Capital Ltd. He has 25 years of experience in strategy development, corporate governance and investment management across various industries worldwide. He was a finalist for the Ernst & Young Entrepreneur of the Year 2011.
Nelson Quan
Managing Partner
Managing Director of CE Venture Capital's Calgary office. His interests include new technologies and solutions in healthcare, medical care, and biosciences. Prior to joining CE Venture Capital, he founded a start-up and worked in venture investing for over six years in both China and North America. He holds degrees in medicine and finance.
Tina Zhao
Principal
Joined CE Venture Capital in 2018 and is currently Vice President in the Vancouver office. Prior to joining, she worked in M&A and FP&A at Finning International, in Corporate Development and Strategic Planning at CHC Helicopters, and began her career in Clean Technology and Diversified Investment Banking at CIBC. She holds a Bachelor of Commerce in Finance and Economics from the University of British Columbia, is a CFA charterholder, and co-founded the largest undergraduate venture capital competition in North America.
William Song
Managing Partner
Managing Director of CE Venture Capital China, responsible for overseeing and developing the firm's China projects. Prior to joining CE Venture Capital, he had a 15-year career in the North American energy industry and China's consumer products industry, focused on strategic development, finance and market insights. He holds a Bachelor of Economics, Finance and Accountancy.
Robert Giles
Managing Partner
Managing Director at CE Venture Capital, member of the Investment Committee, and responsible for portfolio construction and risk management. He has a 25-year career in venture capital, private equity, investment banking and corporate advisory, with experience in due diligence, deal origination, finance and structuring. He has been involved in $15 billion of financings and M&A transactions and has been an active angel investor for 15 years.
Portfolio Companies (60)
Other
Think Bioscience
Biotechnology company using synthetic biology-enabled platforms to design small-molecule therapies for undruggable targets.
CrossBridge Bio
Biotech company developing dual-payload antibody-drug conjugates (ADCs) for solid tumors.
Exeliom Biosciences
Developer of microbiome-based therapies in immuno-oncology and immuno-inflammation.
Freya Biosciences
Clinical-stage biotech focused on microbial immunotherapies for women’s reproductive health.
XCath
Medical device company pioneering neuro-endovascular surgical robotics.
EndoQuest Robotics
Developer of next-generation microsurgical robotic systems for minimally invasive and endoluminal procedures.
Endeavor Biomedicines
Clinical-stage precision medicine company developing therapies for terminal diseases such as oncology and fibrosis.
Prime Medicine
Genomics company using prime editing gene-editing technology to address disease-causing mutations.
Solace Health
Digital health platform connecting patients with healthcare advocates who navigate the system on their behalf.
Applied Intuition
Provider of vehicle intelligence toolchain, OS, and autonomy stacks for OEMs and defense.
- •Address your outreach to a specific partner, such as Bruce Hong, General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Fundraising resources
Frequently Asked Questions
See if CE Ventures is a match for your startup
Upload your pitch deck to see how well you match with CE Ventures and 10,000+ other investors.
Is this your profile? Request a correction or removal